Eyal Neria

Mitoconix Bio Ltd. develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases. The company was founded by Daria Mochly-Rosen in August 2016 and is headquartered in Ness Ziona, Israel.

Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel.

CapsuTech Ltd. develops polymers for drug targeting and encapsulation. It is a product driven startup company focuses on research and development of semi-natural, peptide-based, polymers for drug targeting and encapsulation of various chemical and biological entities such as drugs, cosmetics, vitamins, food additives, proteins, virions and even cells. The company was founded by Jallal M. Gnaim in May 2006 and is headquartered in Nazareth, Israel.